The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
ConditionOpioid Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-60
SponsorAjou University School of Medicine
About this trial
Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients (19-60 years old) with ASA physical status 1, 2, 3
Scheduled surgery under general anesthesia
Disqualifiers
The patient does not conset
Pregnancy
hepatic disorder
Renal disorder
Trial design
Design model
Parallel
Treatments tested in this trial
Maxigesic administration
DrugPreoperative Maxigesic IV administration
Treatment groups
96 Participants
are divided into 2 treatment groupsGroup A: Maxigesic groupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Remifentanil requirement
Intraoperative remifentanil requirement
Time frame
3 hours, from incision to skin closureSecondary outcomes
1
postoperative analgesic requirement
postoperative fentanyl requirement
Time frame
1 hour, while in the recovery roomSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov